<DOC>
	<DOCNO>NCT00460577</DOCNO>
	<brief_summary>To determine efficacy tolerability inhale Formoterol v nebulized Ipatropioum Bromide plus Fenoterol cumulative sequential dos asthmatic child ( 5- &lt; 12 year ) acute bronchial obstruction attend emergency service</brief_summary>
	<brief_title>Efficacy Formoterol v Ipatropioum Bromide Plus Fenoterol Children ( 5- &lt; 12 Years ) With Acute Bronchial Obstruction</brief_title>
	<detailed_description />
	<mesh_term>Fenoterol</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Fenoterol , ipratropium drug combination</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Asthmatic child 5 &lt; 12 year old , require emergency service acute bronchial obstruction mild moderate determine functional clinical evidence Patients severe acute bronchial obstruction determine functional clinical evidence Patients unable use inhale device time treatment Patients receive bronchodilator drug within last 12 hour Patients receive inhaled steroid within last 72 hour Patients receive systemic steroid within last 7 day Patients near fatal asthma history Patients fever ( &gt; 38.5Â°C axillar temp ) Patients clinical significance condition Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Asthma , Formoterol , Bronchial Obstruction , Children</keyword>
</DOC>